Lv21
106 积分 2025-08-08 加入
Osimertinib With or Without Chemotherapy in Advanced Non–Small Cell Lung Cancer With EGFR and Concurrent TP53 Mutations
3小时前
已完结
Osimertinib With or Without Chemotherapy in Advanced Non–Small Cell Lung Cancer With EGFR and Concurrent TP53 Mutations
3小时前
已完结
Osimertinib With or Without Chemotherapy in Advanced Non–Small Cell Lung Cancer With EGFR and Concurrent TP53 Mutations
4天前
已完结
Osimertinib With or Without Chemotherapy in Advanced Non-Small Cell Lung Cancer With EGFR and Concurrent TP53 Mutations: A Randomized Clinical Trial
4天前
已完结
[Play the "combo fist" in the diagnosis and treatment of advanced gastric cancer]
8个月前
已完结
Evaluation of the Efficacy of Second-Line Therapy for Metastatic Gastric Cancer in Real Clinical Practice - the Results of a Multicenter Retrospective Study: Experience of Moscow Oncology Service
9个月前
已关闭
Evaluation of the Efficacy of Second-Line Therapy for Metastatic Gastric Cancer in Real Clinical Practice - the Results of a Multicenter Retrospective Study: Experience of Moscow Oncology Service
9个月前
已关闭
Outcomes of Ramucirumab Plus Paclitaxel Among Patients With Previously Treated Metastatic Gastric/Lower Esophageal Cancer
9个月前
已完结
Treatment effect of apatinib combined chemotherapy as second-line or above therapy in patients with advanced gastric cancer or adenocarcinoma of the gastroesophageal junction
9个月前
已完结
皖公网安备34019202002308
